NDC 72162-1813-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1813
- Requested NDC
- 72162-1813-01
- Package NDCs from labels
- 72162-1813-1, 72162-1813-2, 72162-1813-4, 72162-1813-6, 72162-1813-7, 72162-1813-8, 72162-1813-9, 72162-1813-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1813-1 | Gabapentin | 100 in 1 BOTTLE | CAPSULE | 100 | 103 | |
| 72162-1813-2 | Gabapentin | 120 in 1 BOTTLE | CAPSULE | 120 | 103 | |
| 72162-1813-4 | Gabapentin | 20 in 1 BOTTLE | CAPSULE | 20 | 103 | |
| 72162-1813-6 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 103 | |
| 72162-1813-7 | Gabapentin | 180 in 1 BOTTLE | CAPSULE | 180 | 103 | |
| 72162-1813-8 | Gabapentin | 84 in 1 BOTTLE | CAPSULE | 84 | 103 | |
| 72162-1813-9 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 103 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1813 | GABAPENTIN CAPSULE [BRYANT RANCH PREPACK] | 103 | Current NDC, 7 package rows | 20241122_7b404ab9-8a7e-49d4-920f-487875d14e45.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1813-1 | EA - Each | 72162-1813 | 8856c4e8-137b-44a5-808d-f98066f19826 | 1 | 2023-10-16 |
| 72162-1813-2 | EA - Each | 72162-1813 | a183c871-091d-44cf-9543-d7001ec1c283 | 1 | 2023-10-16 |
| 72162-1813-4 | EA - Each | 72162-1813 | b07e71dd-2f20-45ee-991b-6c6439d04975 | 1 | 2023-10-16 |
| 72162-1813-6 | EA - Each | 72162-1813 | 9e445edb-c461-4927-b6b3-e05adc58973d | 1 | 2023-10-16 |
| 72162-1813-7 | EA - Each | 72162-1813 | c96e5a2f-b40c-487c-ba7d-b9d07d0426c2 | 1 | 2023-10-16 |
| 72162-1813-8 | EA - Each | 72162-1813 | 67d0ac8a-2d12-4499-a0a3-e52e90e6285b | 1 | 2023-10-16 |
| 72162-1813-9 | EA - Each | 72162-1813 | ab614c8e-b9c9-4442-bd0b-61e9a0f3be0e | 1 | 2023-10-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Strides Pharma Science Limited | 798575b9-ddfa-4915-9574-626abbaf025f | 2026-04-04 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 75caca13-1432-4c0d-8d45-f029b0b2d417 | 2026-03-31 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 56378630-e7a7-4981-8212-8ea703a433d8 | 2026-03-31 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | ST. MARY'S MEDICAL PARK PHARMACY | 4ddc1342-5c83-f562-e063-6294a90a29ba | 2026-03-25 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advanced Rx of Tennessee, LLC | afc83432-8fce-6d2a-e053-2a95a90ae73f | 2026-03-19 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 81774da8-cb1d-4c7d-8550-35396850d5ff | 2026-03-18 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 912d8697-b466-48dc-88d3-d2ba90e76644 | 2026-03-12 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Radha Pharmaceuticals, Inc. | 1045db4e-4c76-4a0d-bf12-019bd96a8f59 | 2026-03-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Direct_Rx | 0b286fd1-8179-d87a-e063-6294a90a2f23 | 2026-03-05 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | American Health Packaging | e00f5048-1a06-44f4-b244-aa2755f4be22 | 2026-03-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Solco Healthcare US, LLC | 360d953b-4313-45ae-b933-296547d4577d | 2026-02-28 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 54c09aa5-6724-480a-a115-c88484e39e93 | 2026-02-24 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advagen Pharma Ltd | 401b30fc-e143-4906-aae1-e5b5c190d4a8 | 2026-02-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advagen Pharma Ltd | bfee67dc-d2b1-4a00-92d9-a42be3189c74 | 2026-02-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | ScieGen Pharmaceuticals, Inc. | 5ab9c18b-9568-4dcb-90b0-252aef8f8dc2 | 2026-02-20 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 9814b76c-87c6-4746-b712-3269352a901b | 2026-02-16 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | d8daa30f-1cb3-46aa-9b68-d9aa5b0a2105 | 2026-02-12 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | c979f80b-d4b1-40f7-b878-b216db5f325d | 2026-02-10 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | b88b0cbc-c883-4d17-8f46-0e5bddc57835 | 2026-02-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 3dbd447f-4791-4c62-86b4-6f7928862785 | 2026-02-10 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.